Larvol Delta - A-Study-to-Evaluate-the-Usability-of-the-SB11-PFS-in-Trial-Participants-With-Wet-AMD-Macular-Oedema-Secondary-to-RVO-or-mCNV

Byooviz (ranibizumab-nuna) - Samsung, AffaMed Therap, Biogen, Harrow Health

Lucentis (ranibizumab) - Roche, Novartis

http://clinicaltrials.gov/ct2/show/NCT07550504

Apr 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next